AstraZeneca aims to begin design and construction of the manufacturing facility by the end of this year.
SINGAPORE – AstraZeneca will invest US$1.5 billion in building a manufacturing facility in Singapore for antibody drug conjugates (ADCs), the biopharmaceutical giant…

















